Evaluable Patient

Known as: evaluable patients 
Patients whose response to a treatment can be measured because enough information has been collected.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1971-2018
024619712018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Following national recommendations, palivizumab is administered in Germany to high-risk infants to prevent… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND The randomized phase II OPUS (Oxaliplatin and Cetuximab in First-Line Treatment of Metastatic Colorectal Cancer) study… (More)
Is this relevant?
Highly Cited
2011
Highly Cited
2011
PURPOSE Observational studies suggested that luteinizing hormone-releasing hormone agonists (LHRHa) might prevent premature… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 4
Is this relevant?
2005
2005
Fluorescence in situ hybridization with a chromosome 12-specific a-centromeric probe and a 13q14 yeast artificial chromosome… (More)
  • table I
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To evaluate the relative efficacy of (1) individual cognitive-behavioral family-based therapy (CBFT); (2) group CBFT… (More)
Is this relevant?
2002
2002
Purpose: This study addressed theefficacy and toxicity of the novel compoundBryostatin-1 (NSC 339555), a novel agentwith… (More)
Is this relevant?
2000
2000
This randomized, observer-blind, multicenter, parallel-group study compared the clinical and bacteriologic efficacy and safety of… (More)
Is this relevant?
1998
1998
This randomized, multicenter, open-label study compared the efficacy and safety of monotherapy with 2 g of intravenous… (More)
Is this relevant?
1998
1998
The aims of the present open, randomized, single-blind (patient), single institution, phase II study were: i) to compare the… (More)
Is this relevant?
1997
1997
BACKGROUND Ranitidine bismuth citrate (RBC) 400 mg when given twice daily (b.d.) for 4 weeks with clarithromycin 250 mg four… (More)
Is this relevant?